Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
06/2005
06/09/2005WO2005051305A2 Enhanced drug delivery
06/09/2005WO2005051304A2 Akt protein kinase inhibitors
06/09/2005WO2005051303A2 Screening for synergistic compounds
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051299A2 Metalloproteinase-binding proteins
06/09/2005WO2005051298A2 Novel phosphorus-containing thyromimetics
06/09/2005WO2005051297A2 Combination drug therapy to treat obesity
06/09/2005WO2005051296A2 Fused ring dicationic anti-protozoan agents and their prodrugs
06/09/2005WO2005051295A2 Asymmetrically branched polymer conjugates and microarray assays
06/09/2005WO2005051294A2 Recovery of phytonutrients from oils
06/09/2005WO2005051291A2 B-cell-targeted toxin for immuno response reduction
06/09/2005WO2005051290A2 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
06/09/2005WO2005051289A2 Homogeneous preparations of chimeric proteins
06/09/2005WO2005051287A2 Method and device for umbilicus protection during abdominal surgery
06/09/2005WO2005051286A2 Stable ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-yloxy) methyl)-2-amine-1h-purin-6(9h)-one.
06/09/2005WO2005039489A3 Compositions and methods for the inhibition of bone growth and resorption
06/09/2005WO2005037198A3 Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
06/09/2005WO2005034843A3 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
06/09/2005WO2005032473A3 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials
06/09/2005WO2005030136A3 Tumor vaccine
06/09/2005WO2005023177A3 Human monoclonal antibodies against bacillusanthracis protective antigen
06/09/2005WO2005020933A3 Nanoparticles for drug-delivery
06/09/2005WO2005020914A3 Pyridomorphinans, pyridazinomorphinans and use thereof
06/09/2005WO2005020910A3 Cyclooxygenase-2 selective inhibitor and corticotropin releasing factor antagonist compositions for treating ischemic mediated cns disorders or injuries
06/09/2005WO2005018564A3 Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage
06/09/2005WO2005016286A3 Pyrazine modulators of cannabinoid receptors
06/09/2005WO2005013903A3 Derivatives of substituted quinone and uses thereof
06/09/2005WO2005011609A3 Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
06/09/2005WO2005011579A3 Treatment of dependence withdrawal
06/09/2005WO2005009356A3 Method for the preparation of controlled release formulations
06/09/2005WO2005007092A3 Novel chemical compounds
06/09/2005WO2005002513A3 C1q complement inhibitors and methods of use thereof
06/09/2005WO2005002510A3 Deployable multifunctional hemostatic agent
06/09/2005WO2005000248A3 Compositions and methods for skin conditioning
06/09/2005WO2005000227A3 Methods of treating tnf-mediated disorders
06/09/2005WO2004110345A3 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
06/09/2005WO2004105685A3 Displaceable linker solid phase chemical ligation
06/09/2005WO2004103288A3 Method of preventing recurrent miscarriages
06/09/2005WO2004096149A3 Industrially scalable nucleoside synthesis
06/09/2005WO2004082614A3 Methods for treating cancer using perna canaliculus component(s) and extracts of perna canaliculus
06/09/2005WO2004080410A3 Furanose-type bicyclic carbohydrates with biological activity
06/09/2005WO2004080403A3 Influenza virus vaccine
06/09/2005WO2004062623A3 Method of treating functional bowel disorders
06/09/2005WO2004062558A3 Process for enzymatic synthesis of βετα-lactam antibiotics
06/09/2005WO2004043383A8 A new target for angiogenesis and anti-angiogenesis therapy
06/09/2005WO2004038428A3 Controlled-release compositions
06/09/2005WO2004034982A3 Treatment termination in a medical device
06/09/2005WO2004026223A3 CONTINUOUS PROCESS FOR THE PRODUCTION OF OPTICALLY PURE (S)-β HYDROXY-Ϝ-BUTYROLACTONE
06/09/2005US20050125852 Expression vector comprising nucleotide sequences coding protein and/or lipid kinases for use in generating animal models for prevention and treatment of pain, hypertensive, mood, inflammatory, skin, autoimmune, and psychological disorders
06/09/2005US20050124941 Package for pharmaceutical formulation
06/09/2005US20050124628 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders
06/09/2005US20050124622 Compounds and methods for the treatment of pain
06/09/2005US20050124580 Bis[(dihydroxyborylphenyl)carbonyloxy]benzenes may be synergistically combined with beta-lactam antibiotics to treat beta-lactam antibiotic resistant bacterial infections
06/09/2005US20050124562 Using Dna polymerase inhibitor as bactericide
06/09/2005US20050124526 Anionic surfactant; cosmetics
06/09/2005US20050124044 Interleukin-21 analogs
06/09/2005US20050124016 Antibodies specific for toxic amyloid beta protein oligomers
06/09/2005US20050123997 Modified fVIII having reduced immunogenicity through mutagenesis of A2 and C2 epitopes
06/09/2005US20050123925 Compositions and methods for the diagnosis and treatment of tumor
06/09/2005US20050123610 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
06/09/2005US20050123602 Includes micelle-forming excipient; increases oral bioavailability; Chlamydia pneumoniae
06/09/2005US20050123588 Hemostatic agent ( microporous polysaccharide microspheres) and a therapeutic agent deposited on chitosan a hemostatic substrate for controlling bleeding caused by surgery or traumatic injuries
06/09/2005US20050123550 Enhances the efficacy and protective immune response of the vaccine by specifically targeting the intradermal compartment of a subject's skin; an antigenic or immunogenic agent and a molecule that enhances the immune response e.g. gelling agent and bioadhesive; no booster shot required
06/09/2005US20050123549 E.g. an antibody that binds the CA6 glycotope conjugated to a cytotoxic agent such as a maytansine; kit with instructions for treating cancer and tumors
06/09/2005US20050123541 Anti-TNF antibodies, compositions, methods and uses
06/09/2005US20050123540 administering synergistic antibodies for treatment of lymphocytic lymphomas and leukemia; immunotherapy
06/09/2005US20050123539 administering molecules that block endogenous costimulatory (B7) interactions with cytotoxic t lymphocytes(CTLA4) and/or CD28 antigens
06/09/2005US20050123534 Humanised antibodies
06/09/2005US20050123527 drug delivery devices comprising multicompartments containing dry nonpathogenic bacterial strains, used for treating gastrointestinal disorders
06/09/2005US20050123514 increasing the transfer of ATP-binding cassette (ABC) transporter expressing cells with retroviral vectors, by contacting with verapamil, diltiazem, quinidine, ritonavir and lentiviruses
06/09/2005US20050123451 Waveguides, projections exclude unwanted portions of fluids; optical fibers, beamsplitters, light sources; packaged as elongated cylinders, flat test strips, and sheets
06/09/2005US20050121631 Thin lightweight flexible cloth, tor treatment of garments with high molecular weight metal particles.
06/09/2005US20050121039 Altering the stiffness, size and/or shape of tissues for breathing disorders and other conditions
06/09/2005CA2648286A1 Systems and methods for altering vestibular biology
06/09/2005CA2547972A1 Fused ring dicationic anti-protozoan agents and their prodrugs
06/09/2005CA2547140A1 Glycopegylated erythropoietin
06/09/2005CA2547085A1 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
06/09/2005CA2547020A1 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
06/09/2005CA2546863A1 Chaperone-based therapy for niemann-pick disease
06/09/2005CA2546861A1 Treatment of a condition in a mammal with administration of compounds and methods of use thereof
06/09/2005CA2546771A1 Plks as modifiers of the beta catenin pathway and methods of use
06/09/2005CA2546763A1 Epha2 agonistic monoclonal antibodies and methods of use thereof
06/09/2005CA2546754A1 Akt protein kinase inhibitors
06/09/2005CA2546747A1 Ttbks as modifiers of the beta catenin pathway and methods of use
06/09/2005CA2546601A1 Novel phosphorus-containing thyromimetics
06/09/2005CA2546583A1 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
06/09/2005CA2546580A1 Homogeneous preparations of chimeric proteins
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546360A1 Methods of treating diseases and disorders by targeting multiple kinases
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546222A1 Methods and reagents for treating, preventing and diagnosing bunyavirus infection
06/09/2005CA2546042A1 Amelioration of macular degeneration and other ophthalmic diseases
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/09/2005CA2545655A1 Combination drug therapy to treat obesity
06/09/2005CA2545653A1 Asymmetrically branched polymer conjugates and microarray assays
06/09/2005CA2543566A1 B-cell-targeted toxin for immuno response reduction
06/09/2005CA2540621A1 Enhanced drug delivery
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 295